265 related articles for article (PubMed ID: 2159367)
1. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
3. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells.
Young MR; Young ME; Lozano Y; Bagash JM
Invasion Metastasis; 1992; 12(5-6):253-63. PubMed ID: 1298738
[TBL] [Abstract][Full Text] [Related]
5. Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones.
Young MR; Young ME; Lozano Y; Coogan M; Bagash JM
Int J Cancer; 1991 Aug; 49(1):150-5. PubMed ID: 1651907
[TBL] [Abstract][Full Text] [Related]
6. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.
Young MR; Newby M; Meunier J
Cancer Res; 1985 Aug; 45(8):3918-23. PubMed ID: 3860290
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
Young MR; Newby M
Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
Young MR; Knies S
J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants.
Fishman D; Galitzki L; Priel E; Segal S
Cancer Res; 1997 Dec; 57(23):5410-5. PubMed ID: 9393768
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
Young MR; Young ME; Kim K
Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
[TBL] [Abstract][Full Text] [Related]
11. The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscle cells: regulation by protein kinase A and protein kinase C.
Ren J; Karpinski E; Benishin CG
J Pharmacol Exp Ther; 1996 Apr; 277(1):394-402. PubMed ID: 8613946
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
Mahan M; Meunier J; Newby M; Young MR
J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
[TBL] [Abstract][Full Text] [Related]
14. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME
Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of signal transduction mechanisms for the mitogenic effects of prostaglandin E2 in normal human bone cells in vitro.
Baylink TM; Mohan S; Fitzsimmons RJ; Baylink DJ
J Bone Miner Res; 1996 Oct; 11(10):1413-8. PubMed ID: 8889840
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
Maca RD
J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
[TBL] [Abstract][Full Text] [Related]
17. Growth stimulation by PGE2 and EGF activates cyclic AMP-dependent and -independent pathways in primary cultures of mouse mammary epithelial cells.
Imagawa W; Bandyopadhyay GK; Wallace D; Nandi S
J Cell Physiol; 1988 Jun; 135(3):509-15. PubMed ID: 2456289
[TBL] [Abstract][Full Text] [Related]
18. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of prostaglandin E1 and indomethacin on the growth and metastasis of transplanted Lewis lung carcinoma in C57BL mice.
Tang DG; Tian HS
Chin Med J (Engl); 1990 Mar; 103(3):208-15. PubMed ID: 2164465
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts.
Kaneki H; Takasugi I; Fujieda M; Kiriu M; Mizuochi S; Ide H
J Cell Biochem; 1999 Apr; 73(1):36-48. PubMed ID: 10088722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
